Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingli Dong

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Annals of the Rheumatic Diseases|July 26, 2020
Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan <i>et al</i>Jixin Zhong, Lingli Dong
International Journal of Emergency Medicine|April 8, 2025
Recurrent Wunderlich syndrome in systemic lupus erythematosus: a case reportYingzi Zhu, Lingli Dong
Seminars in Arthritis and Rheumatism|September 8, 2019
Response to Letter to the EditorJungen Tang, Lingli Dong
Frontiers in Medicine|June 20, 2022
Editorial: Rheumatic Diseases and InfectionLingli Dong, Hisanori Umehara, Jixin Zhong
Journal of Immunology Research|August 29, 2022
The Role of Decorin in Autoimmune and Inflammatory DiseasesYuanji Dong, Jixin Zhong, Lingli Dong
Frontiers in Medicine|September 7, 2021
Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A ReviewYingzi Zhu, Jixin Zhong, Lingli Dong
Clinical and Experimental Rheumatology|August 9, 2021
Role of eosinophilia in IgG4-related diseaseBingxia Ming, Jixin Zhong, Lingli Dong
Clinical and Experimental Medicine|February 22, 2024
Immunomodulatory effects of iTr35 cell subpopulation and its research progressChenxi Yang, Lingli Dong, Jixin Zhong
International Journal of Rheumatic Diseases|May 24, 2021
Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathyZhiqian Bai, Guifen Shen, Lingli Dong
International Immunopharmacology|April 14, 2020
The off-label uses profile of tofacitinib in systemic rheumatic diseasesZichu Zhao, Cong Ye, Lingli Dong
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|July 26, 2020
Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan <i>et al</i>Jixin Zhong, Lingli Dong
International Journal of Emergency Medicine|April 8, 2025
Recurrent Wunderlich syndrome in systemic lupus erythematosus: a case reportYingzi Zhu, Lingli Dong
Seminars in Arthritis and Rheumatism|September 8, 2019
Response to Letter to the EditorJungen Tang, Lingli Dong
Frontiers in Medicine|June 20, 2022
Editorial: Rheumatic Diseases and InfectionLingli Dong, Hisanori Umehara, Jixin Zhong
Journal of Immunology Research|August 29, 2022
The Role of Decorin in Autoimmune and Inflammatory DiseasesYuanji Dong, Jixin Zhong, Lingli Dong
Frontiers in Medicine|September 7, 2021
Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A ReviewYingzi Zhu, Jixin Zhong, Lingli Dong
Clinical and Experimental Rheumatology|August 9, 2021
Role of eosinophilia in IgG4-related diseaseBingxia Ming, Jixin Zhong, Lingli Dong
Clinical and Experimental Medicine|February 22, 2024
Immunomodulatory effects of iTr35 cell subpopulation and its research progressChenxi Yang, Lingli Dong, Jixin Zhong
International Journal of Rheumatic Diseases|May 24, 2021
Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathyZhiqian Bai, Guifen Shen, Lingli Dong
International Immunopharmacology|April 14, 2020
The off-label uses profile of tofacitinib in systemic rheumatic diseasesZichu Zhao, Cong Ye, Lingli Dong
Pageof 20